CATALOGO DEI PRODOTTI DELLA RICERCA

FERDEGHINI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.361
EU - Europa 6.337
AS - Asia 5.521
SA - Sud America 599
AF - Africa 84
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 22.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.258
SG - Singapore 2.598
RU - Federazione Russa 2.139
CN - Cina 1.438
GB - Regno Unito 1.362
BR - Brasile 471
FI - Finlandia 466
HK - Hong Kong 459
FR - Francia 457
DE - Germania 453
IT - Italia 436
VN - Vietnam 419
IE - Irlanda 346
SE - Svezia 318
KR - Corea 192
UA - Ucraina 173
BD - Bangladesh 131
IN - India 63
CA - Canada 51
AR - Argentina 43
TR - Turchia 40
MX - Messico 33
ES - Italia 31
IQ - Iraq 26
JP - Giappone 26
BE - Belgio 24
PL - Polonia 24
EC - Ecuador 23
ID - Indonesia 22
ZA - Sudafrica 22
NG - Nigeria 21
NL - Olanda 21
AT - Austria 19
CO - Colombia 18
PK - Pakistan 16
VE - Venezuela 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
CL - Cile 10
EG - Egitto 10
MA - Marocco 10
NP - Nepal 8
PS - Palestinian Territory 8
PY - Paraguay 8
RO - Romania 8
SA - Arabia Saudita 8
MY - Malesia 7
PH - Filippine 7
UZ - Uzbekistan 7
DK - Danimarca 6
EU - Europa 6
KE - Kenya 6
KZ - Kazakistan 6
LT - Lituania 6
HR - Croazia 5
PE - Perù 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
JO - Giordania 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
IL - Israele 3
JM - Giamaica 3
TH - Thailandia 3
BO - Bolivia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EE - Estonia 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AI - Anguilla 1
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DJ - Gibuti 1
Totale 22.904
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.640
Singapore 1.526
Ashburn 1.210
Southend 1.106
Chandler 1.036
Woodbridge 844
San Jose 751
Ann Arbor 589
Moscow 586
Dallas 570
Hong Kong 453
Houston 414
Dublin 342
The Dalles 328
Verona 232
Wilmington 189
Lawrence 184
Princeton 184
Beijing 143
Nanjing 143
New York 142
Los Angeles 140
Ho Chi Minh City 139
Sindelfingen 131
Boardman 111
Buffalo 104
Helsinki 94
Jinan 90
Shenyang 88
Hebei 85
Hanoi 80
Tianjin 70
Philadelphia 61
Council Bluffs 60
Changsha 56
Santa Clara 54
Nanchang 46
Detroit 45
Milan 45
São Paulo 43
Columbus 42
Hangzhou 42
Zhengzhou 41
Haikou 37
Jiaxing 37
Dong Ket 36
Norwalk 35
Ningbo 34
Munich 33
Guangzhou 30
Chicago 28
Orem 25
Redondo Beach 25
Brussels 24
Falls Church 24
Bologna 22
Taizhou 22
Tokyo 22
San Francisco 21
Toronto 21
Washington 21
Abuja 20
Warsaw 19
Auburn Hills 17
Frankfurt am Main 17
Lanzhou 17
Chennai 16
Rio de Janeiro 16
Taiyuan 16
Brooklyn 15
Dearborn 15
Lancaster 15
Tappahannock 15
Da Nang 14
Montreal 14
Phoenix 14
Seattle 14
Stockholm 14
Düsseldorf 13
London 13
Shanghai 13
Turku 13
Atlanta 12
Bắc Ninh 11
Haiphong 11
Vienna 11
Amsterdam 10
Biên Hòa 10
Johannesburg 10
Manchester 10
Mexico City 10
Redwood City 10
Baghdad 9
Charlotte 9
Istanbul 9
Rome 9
Seoul 9
Shenzhen 9
Boston 8
Buenos Aires 8
Totale 15.271
Salva come PNG Salva come JPEG
Nome #
[111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas 268
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 253
Gated reconstruction in 18FDG PET-CT quantitative imaging: impact on SUV estimation in lung tumors 218
SU-E-J-168: 4D-PET for Target Volume Delineation in Respiratory-Gated Radiation Therapy. 216
First human Cerenkography. 211
A mathematical model of thyroid mass reduction after radioiodine therapy of Graves’ disease 208
Humanization of care in pediatrics and built-in psychological support in nuclear medicine [Umanizzazione delle cure in età pediatrica e assistenza psicologica integrata in Medicina nucleare] 208
Espressione di Claudina-1 e 7 nel carcinoma papillare della tiroide con comportamento clinico aggressivo 199
Role of dual-point FDG PET/CT in prone position and fused PET/MR; correlation with biologic prognostic parameters in breast cancer 192
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma. 191
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 186
rhTSH-Stimulated Postsurgical Thyroid Remnant Ablation in Differentiated Thyroid Cancer: 1.85 vs 3.7 GBq I-131 Activity 186
Valutazione comparativa dell'acquisizione volumetrica tiroidea con ecografia convenzionale B-Mode (US) ed ecografia volumetrica (VUS) 183
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 182
A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma 181
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology 180
Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal. 178
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinoma 177
A new luminescence immunoassay for thyrotropin using coated tubes: evaluation and comparison with immunoradiometric assay 177
RET mutation and increased angiogenesis in medullary thyroid carcinomas 175
Acute suppression of parathyroid activity during hemofiltration 171
[Primary empty sella syndrome. Clinical and radiological study, and evaluation of pituitary function] 169
Optimized PET Imaging for 4D Treatment Planning in Radiotherapy: the Virtual 4D PET Strategy 166
A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions 165
Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa. 164
Analytical and clinical assessment of a commercial kit for the simultaneous determination of free thyroxine and thyrotropin 162
Age and Gender Substantially Influence the Relationship Between Thyroid Status and the Lipoprotein Profile: Results from a Large Cross-Sectional Study. 161
Serum interleukin-6 levels in uterine malignancies. Preliminary data 159
A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours 159
Multidisciplinary approach including receptor radionuclide therapy with 90Y-DOTATOC ([90Y-DOTA0, Tyr3]-octreotide) and 177Lu-DOTATATE ([177Lu-DOTA0, Tyr3]-octreotate) in ectopic cushing syndrome from a metastatic gastrinoma: a promising proposal. 158
[Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system] 156
[Bromocriptine therapy from the 2d month of pregnancy induces regression of neuro-ophthalmologic complications caused by macroprolactimona] 156
[Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer] 149
Serum CYFRA 21-1 assay in squamous cell carcinoma of the cervix 147
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary] 146
Comparison of plasma and urinary methods for the direct measurement of the thyroxine to 3,5,3' - triiodothyronine conversion rate in man 146
Clinical validation of the new ELSA-CA 125 II assay: report of a European multicentre evaluation 144
Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits 142
Relation of fetal growth to maternal responses to oral glucose tolerance test throughout gestation 142
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between rhTSH stimulation and prolonged levothyroxine withdrawal. 142
Functional Imaging and Peptide Receptor Radionuclide Therapy 141
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer 140
A computer program for customized recommendations to radioiodine-treated patients [Studio e realizzazione di un programma computerizzato per prescrizioni personalizzate a pazienti iodiotrattati in dimissione] 139
Blood markers of early and late airway responses to allergen in asthmatic subjects. Relationship with functional findings 138
Determination of serum levels of different cytokeratins in patients with uterine malignancies 135
Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty 135
Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer 134
[Comparison of serum determinations of CA125, CA15-3 and CA50 in the preoperative evaluation of adnexal tumors] 134
Tumor-associated trypsin inhibitor (TATI) and renal function 133
[Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary] 133
Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis. 133
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancer 132
Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. 132
Plasma leptin levels in newborns from normal and diabetic mothers. 131
Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer 130
Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses 130
Anticlastogenic Effect of Ginkgo biloba Extract in Graves' Disease Patients Receiving Radioiodine Therapy 130
CA 195: a new monoclonal antibody-defined Lea blood group-related tumor marker in patients with epithelial ovarian cancer 129
The relationship between maternal relaxation and plasma beta-endorphin levels during parturition 129
External quality control survey for alpha-fetoprotein assay 129
Autonomous thyroid nodule and percutaneous ethanol injection [letter] [see comments] 128
Effect of anabolic treatment on the serum levels of gonadotropins, testosterone, prolactin, thyroid hormones and myoglobin of male athletes under physical training 128
Radioimmunoassay of unconjugated and total serum estetrol using a 125I-iodinated tracer 128
Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma 127
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients 127
T-helper 1 and 2 activation with fresh or cultured allo- or xenoislets 127
Serum tumour-associated trypsin inhibitor (TATI) and renal function 126
Carcinoid crisis induced by receptor radionuclide therapy with 90Y-DOTATOC in a case of liver metastases from bronchial neuroendocrine tumor (atypical carcinoid). 126
Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure 125
Percutaneous ethanol injection treatment of autonomous thyroid adenoma: hormonal and clinical evaluation [see comments] 124
Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors 123
Hypothalamo-pituitary function in four cases of true precocious puberty 123
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancer 122
Comet assay on children's leukocytes 8 years after the Chernobyl disaster 122
Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia 122
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma 122
Anomalous between-laboratory variability in a collaborative study of carcinoembryonic antigen immunoassay [letter] 122
Can insulin action induce myocardial texture alterations in essential hypertension? 122
Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders 121
Preoperative D-dimer plasma assay is not a predictor of clinical outcome for patients with advanced ovarian cancer 121
The measurement of plasma D-dimer (DD) levels in the follow-up of patients with ovarian cancer 121
Effects of the ablation of the submaxillary gland on the rat testis 121
Preoperative serum E-cadherin assay in patients with ovarian carcinoma 120
Serum anti-p53 antibodies in the follow-up of patients with advanced ovarian carcinoma 119
Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. 119
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: relevance for differential diagnosis 118
Somatotropic axis and body weight in pre-menopausal and post-menopausal women: evidence for a neuroendocrine derangement, in absence of changes of insulin-like growth factor binding protein concentrations 118
Relationship between the circulating levels of adenohypophyseal hormones in blood and in cerebrospinal fluid 118
Human placental lactogen (hPL) deficiency in a normal pregnancy 118
Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration 118
Pancreatic cancer and tumor markers: role of the newly identified CAR-3 antigen 117
The trend of serum CA125 levels during the first three courses of chemotherapy as a predictor of second-look findings in patients with ovarian carcinoma 117
Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. 117
Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. 117
Role of neck ultrasonography in the follow-up of patients operated on for thyroid cancer 116
Differential diagnosis of adnexal masses with transvaginal sonography, color flow imaging, and serum CA 125 assay in pre- and postmenopausal women 116
Role of serum carrier proteins in the peripheral metabolism and tissue distribution of thyroid hormones in familial dysalbuminemic hyperthyroxinemia and congenital elevation of thyroxine-binding globulin 116
Human seminal transferrin: correlation with seminal and hormonal parameters 116
Hyperprolactinemic amenorrhea induced by an intrasellar epithelial cyst 116
Soluble interleukin-2 receptor release during culture of human lymphocytes with human, porcine, or bovine islets and the effect of culture and cryopreservation 115
Totale 14.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.451
article - articoli 73.595
book - libri 0
conference - conferenze 2.635
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.221
Totale 154.902
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202179 0 0 0 0 0 0 0 0 0 0 0 79
2021/2022955 38 121 7 37 35 24 13 81 81 49 127 342
2022/20232.784 228 176 256 505 351 599 15 238 274 17 85 40
2023/20241.097 79 143 109 257 86 136 24 35 7 13 115 93
2024/20252.780 250 192 31 497 158 39 30 165 506 168 228 516
2025/20268.541 683 459 659 1.060 1.819 550 1.160 528 694 477 218 234
Totale 22.968